Eckert & Ziegler and AtomVie sign global supply agreement for Lutetium-177

Eckert & Ziegler will supply its n.c.a. Lutetium-177 chloride (Theralugand®) to AtomVie Global Radiopharma for its CDMO activities in radiopharmaceutical manufacturing. The agreement covers early and late-stage development and global programs.

“We are happy to support AtomVie in advancing global radiopharmaceutical development programs with Theralugand®.”webdisclosure.com

• 1 source
• webdisclosure.comEckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ) |Eckert, Ziegler Strahlen- Und Medizintechnik AGMar 20, 2025

Summarized from public sources; check the original articles before acting on it.